These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34767933)

  • 1. The inclusion of leukocytes into platelet rich plasma reduces scaffold stability and hinders extracellular matrix remodelling.
    Anitua E; Zalduendo M; Troya M; Tierno R; Alkhraisat MH
    Ann Anat; 2022 Feb; 240():151853. PubMed ID: 34767933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular composition modifies the biological properties and stability of platelet rich plasma membranes for tissue engineering.
    Anitua E; Zalduendo M; Troya M; Tierno R; Alkhraisat MH
    J Biomed Mater Res A; 2023 Nov; 111(11):1710-1721. PubMed ID: 37318048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion.
    Anitua E; Zalduendo MM; Prado R; Alkhraisat MH; Orive G
    J Biomed Mater Res A; 2015 Mar; 103(3):1011-20. PubMed ID: 24890049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties.
    Anitua E; Zalduendo M; Troya M; Padilla S; Orive G
    PLoS One; 2015; 10(3):e0121713. PubMed ID: 25823008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma rich in growth factors (PRGF) and leukocyte-platelet rich fibrin (L-PRF): comparative release of growth factors and biological effect on osteoblasts.
    Baca-Gonzalez L; Serrano Zamora R; Rancan L; González Fernández-Tresguerres F; Fernández-Tresguerres I; López-Pintor RM; López-Quiles J; Leco I; Torres J
    Int J Implant Dent; 2022 Oct; 8(1):39. PubMed ID: 36184700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Proteomic Analysis of Human Dermal Fibroblast Response to Different Blood Derivatives: Autologous Topical Serum Derived from Plasma Rich in Growth Factors (PRGF) versus Leukocyte- and Platelet-Rich Plasma (L-PRP).
    Anitua E; Pino A; Azkargorta M; Elortza F; Prado R
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblastic response to treatment with different preparations rich in growth factors.
    Anitua E; Sánchez M; Zalduendo MM; de la Fuente M; Prado R; Orive G; Andía I
    Cell Prolif; 2009 Apr; 42(2):162-70. PubMed ID: 19250293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozone dosing alters the biological potential and therapeutic outcomes of plasma rich in growth factors.
    Anitua E; Zalduendo MM; Troya M; Orive G
    J Periodontal Res; 2015 Apr; 50(2):240-7. PubMed ID: 24957247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of platelet-rich or growth factor-rich plasma on intestinal anastomosis healing in pigs.
    Giusto G; Vercelli C; Iussich S; Tursi M; Perona G; Gandini M
    BMC Vet Res; 2017 Jun; 13(1):188. PubMed ID: 28629420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery.
    Anitua E; Muruzabal F; Alcalde I; Merayo-Lloves J; Orive G
    Exp Eye Res; 2013 Oct; 115():153-61. PubMed ID: 23872360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic characteristics of plasma rich in growth factors (PRGF): blood cell components and biological effects.
    Nishiyama K; Okudera T; Watanabe T; Isobe K; Suzuki M; Masuki H; Okudera H; Uematsu K; Nakata K; Kawase T
    Clin Exp Dent Res; 2016 Nov; 2(2):96-103. PubMed ID: 29744155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.
    Anitua E; de la Fuente M; Sánchez-Ávila RM; de la Sen-Corcuera B; Merayo-Lloves J; Muruzábal F
    Curr Eye Res; 2023 May; 48(5):456-464. PubMed ID: 36695530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Bielecki T; Jimbo R; Barbé G; Del Corso M; Inchingolo F; Sammartino G
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1145-52. PubMed ID: 21740377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte-Reduced Platelet-Rich Plasma Normalizes Matrix Metabolism in Torn Human Rotator Cuff Tendons.
    Cross JA; Cole BJ; Spatny KP; Sundman E; Romeo AA; Nicholson GP; Wagner B; Fortier LA
    Am J Sports Med; 2015 Dec; 43(12):2898-906. PubMed ID: 26460099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-Released Growth Factors and Platelet-Rich Fibrin Induce Expression of Factors Involved in Extracellular Matrix Organization in Human Keratinocytes.
    Bayer A; Wijaya B; Möbus L; Rademacher F; Rodewald M; Tohidnezhad M; Pufe T; Drücke D; Gläser R; Harder J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of sodium citrate on the characteristics and biological activity of plasma rich in growth factors.
    Anitua E; Zalduendo M; Troya M; Alkhraisat MH
    Regen Med; 2020 Oct; 15(10):2181-2192. PubMed ID: 33275449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.